Cardinal Health Inc (CAH)

Return on equity (ROE)

Jun 30, 2025 Jun 30, 2024 Jun 30, 2023 Jun 30, 2022 Jun 30, 2021
Net income US$ in thousands 1,561,000 852,000 330,000 -933,000 611,000
Total stockholders’ equity US$ in thousands -2,781,000 -3,213,000 -2,958,000 -709,000 1,791,000
ROE 34.12%

June 30, 2025 calculation

ROE = Net income ÷ Total stockholders’ equity
= $1,561,000K ÷ $-2,781,000K
= —

The analysis of Cardinal Health Inc.'s return on equity (ROE) over the specified period indicates that for the fiscal year ending June 30, 2021, the ROE was 34.12%, reflecting a relatively strong return generated on shareholders' equity. However, there is a notable absence of ROE data beyond this date, extending through June 30, 2022, June 30, 2023, June 30, 2024, and June 30, 2025. The missing data suggests that the company either did not report ROE figures in subsequent periods or that the values were not available at the time of data compilation.

This lack of continuity in ROE data precludes a definitive assessment of trends or performance consistency moving forward. Without additional figures, it is not possible to ascertain whether the company experienced improvements, declines, or stability in its profitability relative to shareholders’ equity in subsequent periods. Therefore, the current analysis highlights a single data point in June 2021, with no comparative figures provided for later years, limiting insights into the company's evolving efficiency in generating earnings relative to equity over time.


Peer comparison

Jun 30, 2025

Company name
Symbol
ROE
Cardinal Health Inc
CAH
Cencora Inc.
COR
233.63%
McKesson Corporation
MCK